Weight loss medication comparison
Weight loss medication comparison
Compare GLP-1 injections, dual agonists, oral medicines and established prescription options for medical weight loss.
Medication classes differ substantially
Prescription weight-loss medications work through different pathways. Average trial results cannot predict an individual outcome, and cross-trial percentages are not head-to-head comparisons. Treatment should be combined with nutrition, physical activity, sleep and behavioral support.
Major chronic weight-management options
| Medication | Route/mechanism | Important considerations |
|---|---|---|
| Zepbound (tirzepatide) | Weekly GIP/GLP-1 injection | GI effects; thyroid C-cell tumor boxed warning; also approved for certain adults with obesity and moderate-to-severe OSA |
| Wegovy (semaglutide) | Weekly GLP-1 injection | GI effects; thyroid warning; cardiovascular-risk reduction indication in certain adults |
| Foundayo (orforglipron) | Daily oral GLP-1 medicine | New 2026 oral option; follow current label for titration and contraindications |
| Saxenda (liraglutide) | Daily GLP-1 injection | Daily dosing; GI effects and thyroid warning |
| Qsymia | Oral phentermine/topiramate | Pregnancy prevention, mood/cognitive, heart-rate and glaucoma considerations |
| Contrave | Oral naltrexone/bupropion | Avoid with opioids, seizure disorders and uncontrolled hypertension |
| Orlistat | Oral intestinal lipase inhibitor | GI effects, vitamin absorption and kidney-stone warning considerations |
Short-term and off-label options
Phentermine, diethylpropion and phendimetrazine are sympathomimetic medicines generally labeled for short-term use and require cardiovascular and misuse-risk assessment. Metformin and topiramate are sometimes used off-label in selected situations. Off-label use must be explained and individualized.
How a clinician chooses
Expected benefit
Consider the amount of loss needed to improve diabetes, sleep apnea, mobility or cardiovascular risk.
Safety
Match contraindications and side effects to the patient’s diseases, medicines and pregnancy plans.
Access
A clinically excellent drug that cannot be obtained or continued may not be the practical first choice.
Maintenance
Plan duration, monitoring and alternatives before treatment begins.
How W8MD can help
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised medical weight management in Brooklyn, New York and Northeast Philadelphia, with telehealth when clinically and legally appropriate. Care may include medical evaluation, nutrition planning, body-composition monitoring, prescription medication, sleep evaluation and long-term maintenance.
When an FDA-approved medication is medically appropriate and a plan provides coverage, W8MD can review benefits and help submit prior-authorization documentation. Coverage and approval are determined by the insurer; no medication or result is guaranteed.
W8MD offers a medication-neutral evaluation rather than assuming every patient needs the newest injection. The team can compare GLP-1 and dual-agonist medicines with established oral choices, coordinate prior authorization when coverage exists and monitor response and safety.
Frequently asked questions
Which medication causes the most weight loss?
Trial averages favor some newer incretin therapies, but study populations and designs differ and individual response varies.
Are generic semaglutide and tirzepatide FDA-approved?
No FDA-approved generic versions should be assumed from compounded marketing. Compounded drugs are not FDA-approved.
How long are weight-loss medicines taken?
Chronic medications may be continued while effective, safe and needed; short-term agents have different labeling. Maintenance should be planned individually.
Evidence and authoritative sources
Choose a weight-loss medication with a physician
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised care in Brooklyn, New York and Northeast Philadelphia. Telehealth may be available for eligible patients based on location and applicable requirements.
Contact W8MD
